Luvell Glanton, MD
Pain Medicine · Hannibal, MONPI 1891717781
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Abbott accounts for 60.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $13,705 and has fallen 75.8% since, to $3,321 in 2025. Among pain medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 546 payments — averaging $59.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$20K
- Medtronic$5K
- Nevro Corp.$4K
- Spinal Simplicity, LLC$2K
- Globus Medical$797
- Relievant Medsystems, Inc.$171
- plus $773 from 13 others
What the payments were for
- Consulting fees$3,43011%
- Speaking & faculty fees$5,10016%
- Travel & lodging$5,62117%
- Food & beverage$18,42857%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 366 | $19,573 |
| Medtronic(2 entities) | 90 | $5,258 |
| Nevro Corp. | 43 | $4,450 |
| Spinal Simplicity, LLC | 11 | $1,558 |
| Globus Medical | 7 | $797 |
| Relievant Medsystems, Inc. | 2 | $171 |
| Boston Scientific | 2 | $142 |
| Vertiflex, Inc. | 1 | $110 |
| SPR Therapeutics, Inc | 2 | $102 |
| Tersera Therapeutics LLC | 5 | $91 |
| Pfizer | 4 | $71 |
| Foundation Fusion Solutions, LLC | 2 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Biodelivery Sciences International, Inc. | 2 | $31 |
| AbbVie | 1 | $29 |
| Collegium Pharmaceutical, Inc. | 2 | $24 |
| Bristol Myers Squibb | 1 | $15 |
| Stryker | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$9,202
- Proclaim Family of SCS IPGs$3,202
- Senza Spinal Cord Stimulation System$1,852
- Senza$1,452
- HA MINUTEMAN G3-R$1,446
- INTELLIS ADAPTIVESTIM$1,015
- KYPHON EXPRESS II KYPHOPAK TRAY$886
- Omnia$746
- Proclaim IPG$581
- VANTA ADAPTIVESTIM$436
- INTELLIS$376
- Intracept$299
- SYNCHROMED$137
- INCEPTIV$136
- Vyrsa V1$133
- GENERAL PAIN MANAGEMENT$123
- Superion ISS$110
How this compares
$32,579 in reported general payments places this provider in the 95th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 76 | $74,633 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 953 | $26,697 |
| Nucynta ErTapentadol Hcl | 23 | $26,575 |
| Calcipotriene-BetamethasoneCalcipotriene/Betamethasone | 12 | $16,661 |
| Buprenorphine | 55 | $16,326 |
| Oxymorphone Hcl ErOxymorphone Hcl | 22 | $15,055 |
| OxycontinOxycodone Hcl | 11 | $9,193 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 261 | $8,659 |
| MovantikNaloxegol Oxalate | 18 | $6,885 |
| Morphine Sulfate ErMorphine Sulfate | 220 | $6,505 |
| Hysingla ErHydrocodone Bitartrate | 13 | $5,952 |
| Pregabalin | 160 | $4,466 |
| Morphine Sulfate | 97 | $3,679 |
| Halobetasol Propionate | 26 | $3,534 |
| Clobetasol Propionate | 31 | $3,350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er | $24 | $101,20899 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 124 pain medicine providers in Missouri.
Other pain medicine in Hannibal
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Jooyoung MaengSaint Louis$25K
- Travis FoxxLiberty$23K
- Nabil AhmadSaint Louis$21K
- Chad SheltonSaint Peters$18K
- Katharine GurbaSaint Louis$18K
- Bryan WhitlowBridgeton$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.